IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 67,000 employees worldwide.

ScienceJune 16, 2021
Part One: Leading innovation and collaboration
Webinar report Part One - Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake.
Health PolicyMay 4, 2021
Unleashing the potential of global Britain for life sciences: Part Three
Part Three: Before we are patients, we are people. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
HealthMay 4, 2021
Unleashing the potential of global Britain for life sciences: Part Two
Part Two: Driving change through NHS infrastructure. IQVIA and Public Policy Projects convened a virtual summit of experts to discuss developments in genomics and precision medicine in the context of unleashing the potential of global Britain for life sciences
Health PolicyNovember 25, 2020
Genomics: The roadmap to brighter futures
Speaking at the Public Policy Projects’ (PPP) Annual Conference 2020, a panel of experts discuss how the UK has situated itself as a global leader in genomic research, and the importance that this continues despite the challenges of Covid-19

Become a Partner

If you would like to enquire about working with Public Policy Projects, please contact partnerships@publicpolicyprojects.com for more information.
Public Policy Projects
  • 0207 8399305

ISSN Number: 2517-2662